Drug profile · INN
sevelamer
ARX-SEVELAMER
sevelamer (ARX-SEVELAMER) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd.
EMA: approved TGA: approved Various (V03) V03AE02
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — sevelamer
- Class
- Various (V03)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
sevelamer (ARX-SEVELAMER) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd.
Key facts
INN sevelamer
Brand ARX-SEVELAMER
Therapeutic class Various (V03)
ATC code V03AE02
Originator Sanofi-aventis Healthcare Pty Ltd
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sevelamer?
sevelamer (ARX-SEVELAMER) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd.
What is the brand name for sevelamer?
ARX-SEVELAMER is a marketed brand name for sevelamer. Check FDA Drugs@FDA for the current US label holder and prescribing information.